Global PCR Molecular Diagnostics Market Size (2024 - 2029)

The PCR Molecular Diagnostics market is anticipated to experience significant growth due to its widespread use in detecting pathogens, including viruses like SARS-CoV-2, and its critical role in cancer diagnostics. Technological advancements and increased public awareness of preventive care are key drivers of this market expansion. The rising prevalence of cancer and infectious diseases further contributes to the market's positive trajectory. Additionally, the adoption of software associated with molecular diagnostics in diagnostic centers is expected to enhance market growth.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research In Vitro Diagnostic Devices Research Molecular Diagnostic Devices Research PCR Molecular Diagnostics Industry Market Size

Market Size of Global PCR Molecular Diagnostics

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
alt
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 3.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Global PCR Molecular Diagnostics Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

PCR Molecular Diagnostics Market Analysis

The PCR Molecular Diagnostics market is expected to grow with an estimated CAGR of 3.5%, over the forecast period.

PCR are most widely used diagnostic tests for detecting pathogens, including viruses. It Is considered as one of the best tests to identify the COVID 19 virus in the human body. Additionally, a study titled 'Molecular diagnostic technologies for COVID-19: Limitations and challenges', published on Aug 2020 at NCBI stated that PCR Molecular Diagnostics are used to identify symptomatic or asymptomatic SARS-CoV-2 carriers and is safe and accurate as they have a high clinical sensitivity and avoid false-negative results. Moreover, rising technological advancement and growing public awareness of preventive care are propelling the market growth. Though COVID 19 has a major impact on the medical industry, the PCR Molecular Diagnostics market is on a positive trend.

The rising prevalence of cancer and infectious diseases is also a major factor that drives PCR molecular diagnostics market. The Infectious Diseases Society of America has stated that every year there is a probability of new, potentially dangerous bacteria, viruses, fungi such as severe acute respiratory syndrome (SARS). World Health Organization in March 2020 stated that more than 17% of all infectious diseases are vector born. In addition to this the Global Cancer facts and figures, 4th edition, published at American Cancer Society reported that according to International Agency for Research on Cancer (IARC), the cancer cases are rising and it is expected to reach 27.5 million by 2040, aging is also a supporting factor for the rise in new cancer's.

Adoption and implementation of software associated to molecular diagnostics at respective diagnostics centers is expected to boost the market growth. Aditionally PCR molecular diagnostics also played a crucial role in cancer diseases. For instance, in March 2020, a review made on Important Diagnostic Methods of Cancer Biomarkers related Diagnosis and Treatment reported that Polymerase chain reaction (PCR) & Real Time PCR plays a vital role in cancer diagnostics.

Furthermore, in June 2020, Mobidiag Ltd., announced that it has received CE-IVD markings for its Novodiag COVID-19 and Amplidiag COVID-19 molecular diagnostic tests for the early detection of the SARS-CoV-2 virus, responsible for novel coronavirus infection (COVID-19). Based on well-established high-throughput qualitative PCR technology, 48 samples can be processed in less than three hours while running on Mobidiag's Amplidiag Easy platform. Hence, owing to above mentioned factors, the market is expected to witness significant growth in the future.

PCR Molecular Diagnostics Industry Segmentation

PCR, or the polymerase chain reaction, is a chemical reaction, which is considered to be a molecular technique that is used to amplify the DNA sequences. Short DNA sequences called primers are used to amplify the selected part of the genome. It involves three steps denaturation, Annealing, extension, during which the temperature is raised and lowered which helps the DNA replication enzyme to copy the target DNA sequence, this helps to produce billions of target/desired sequences in few hours. 

The PCR Molecular Diagnostics Market is segmented by Product Type (Instrument, Reagents and Consumables and Software) Application (Infectious Disease Testing, Oncology Testing, Other Applications), End Users (Hospitals, Diagnostics Laboratories, Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Product
Instrument
Standard PCR Systems
Digital PCR Systems
Real-time PCR Systems
Reagents and Consumables
Software
By Application
Infectious Disease Testing
Oncology Testing
Other Applications
By End User
Hospitals
Diagnostic Laboratories
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global PCR Molecular Diagnostics Size Summary

The PCR Molecular Diagnostics market is poised for growth, driven by its critical role in detecting pathogens, including viruses, and its significant application in oncology. Polymerase Chain Reaction (PCR) technology is recognized for its high clinical sensitivity, making it a preferred choice for identifying COVID-19 and other infectious diseases. The market is further bolstered by technological advancements and increased public awareness of preventive healthcare. The rising prevalence of cancer and infectious diseases, alongside the aging population, underscores the demand for PCR diagnostics. The integration of software solutions in diagnostic centers and the adoption of advanced PCR techniques, such as droplet digital PCR, are expected to enhance market expansion. Additionally, strategic mergers and acquisitions among key players aim to strengthen product portfolios and manufacturing capabilities, contributing to the market's positive trajectory.

North America currently holds a significant share of the PCR Molecular Diagnostics market, attributed to the high incidence of diseases, an aging population, and rapid technological advancements. The market's growth is further accelerated by the ongoing need for effective diagnostic solutions in response to pandemics and the increasing incidence of cancer. The use of PCR technology in cancer diagnostics and the early detection of diseases have improved survival rates, particularly in the United States. Major players like Abbott Laboratories, Thermo Fisher Scientific, and Qiagen N.V. dominate the market, leveraging their expertise to meet the rising demand for PCR-based diagnostics. The market's competitive landscape is expected to evolve, with regional players expanding their presence to capitalize on the growing awareness and prevalence of infectious and cancerous diseases.

Explore More

Global PCR Molecular Diagnostics Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Prevalance of Cancer and Infectious Diseases

      2. 1.2.2 Technological Advancements in PCR Devices

      3. 1.2.3 Increasing Demand For Rapid Diagnostic Tests And Growing Adoption of PCR

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of PCR Instrument/Devices

      2. 1.3.2 Stringent Regulatory Policies

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product

      1. 2.1.1 Instrument

        1. 2.1.1.1 Standard PCR Systems

        2. 2.1.1.2 Digital PCR Systems

        3. 2.1.1.3 Real-time PCR Systems

      2. 2.1.2 Reagents and Consumables

      3. 2.1.3 Software

    2. 2.2 By Application

      1. 2.2.1 Infectious Disease Testing

      2. 2.2.2 Oncology Testing

      3. 2.2.3 Other Applications

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Diagnostic Laboratories

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global PCR Molecular Diagnostics Market Size FAQs

The Global PCR Molecular Diagnostics Market is projected to register a CAGR of 3.5% during the forecast period (2024-2029)

Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Takara Bio, Inc and Qiagen N.V. are the major companies operating in the Global PCR Molecular Diagnostics Market.

PCR Molecular Diagnostics Market Report Snapshots

PCR Molecular Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)